NTLA Investors are Suing Intellia Therapeutics, Inc.; Contact Robbins LLP for More Information
Portfolio Pulse from
A class action lawsuit has been filed against Intellia Therapeutics, Inc. (NASDAQ: NTLA) by investors who acquired its securities between June 30, 2024, and January 28, 2025. The lawsuit is being handled by Robbins LLP.
February 20, 2025 | 11:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Intellia Therapeutics is facing a class action lawsuit from investors who purchased its securities between June 30, 2024, and January 28, 2025. This legal action could impact investor sentiment and the company's stock price.
The lawsuit could lead to negative investor sentiment and potential financial liabilities for Intellia Therapeutics, which may negatively impact its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100